These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6088718

  • 1. High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.
    Mortimer JE, Hewlett JS, Bay J, Livingston RB.
    J Neurooncol; 1983; 1(3):269-73. PubMed ID: 6088718
    [Abstract] [Full Text] [Related]

  • 2. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT.
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [Abstract] [Full Text] [Related]

  • 3. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL, Fay JW, Herzig GP, Herzig RH, Weiner RS, Wolff SN, Lazarus HM, Karanes C, Ross WE, Kramer BS.
    Cancer; 1983 Nov 15; 52(10):1792-802. PubMed ID: 6354414
    [Abstract] [Full Text] [Related]

  • 4. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan 15; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 5. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB, Thompson JM, Corwin JA, Mosley KR, Smith MT, de los Reyes RA, Daly MB, Petty AM, Lamaster D, Pierson WP.
    J Clin Oncol; 1987 May 15; 5(5):783-9. PubMed ID: 3553437
    [Abstract] [Full Text] [Related]

  • 6. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB, Soffietti R, Riva A, Stura G, Sales S, Schiffer D.
    Neuroradiology; 1992 May 15; 34(1):73-6. PubMed ID: 1313161
    [Abstract] [Full Text] [Related]

  • 7. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK, Selby PJ, Perren TJ, Dearnaley DP, Whitton A, Ashley S, Workman P, Bloom HJ, McElwain TJ.
    Br J Cancer; 1988 Dec 15; 58(6):779-82. PubMed ID: 2852028
    [Abstract] [Full Text] [Related]

  • 8. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
    Phillips GL, Wolff SN, Fay JW, Herzig RH, Lazarus HM, Schold C, Herzig GP.
    J Clin Oncol; 1986 May 15; 4(5):639-45. PubMed ID: 3009725
    [Abstract] [Full Text] [Related]

  • 9. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ, Malkin MG, Kleber M, Abrey LE.
    Neuro Oncol; 2004 Jul 15; 6(3):247-52. PubMed ID: 15279717
    [Abstract] [Full Text] [Related]

  • 10. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Cascino TL, Burch PA, Dinapoli RP.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):297-302. PubMed ID: 9457812
    [Abstract] [Full Text] [Related]

  • 11. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
    Sai K, Zhong MG, Wang J, Chen YS, Mou YG, Ke C, Zhang XH, Yang QY, Lin FH, Guo CC, Chen ZH, Zeng J, Lv YC, Li X, Gao WC, Chen ZP.
    J Neurol Sci; 2014 Aug 15; 343(1-2):60-5. PubMed ID: 24874252
    [Abstract] [Full Text] [Related]

  • 12. BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
    Levin VA, Hoffman WF, Pischer TL, Seager ML, Boldrey EB, Wilson CB.
    Cancer Treat Rep; 1978 Dec 15; 62(12):2071-6. PubMed ID: 221113
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Reid JM, Bagniewski PJ, Ames MM, Cascino TL, Marks RS.
    Int J Radiat Oncol Biol Phys; 1998 Dec 01; 42(5):969-75. PubMed ID: 9869217
    [Abstract] [Full Text] [Related]

  • 15. BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide.
    Rosenthal MA, Ashley DL, Cher L.
    J Clin Neurosci; 2004 May 01; 11(4):374-5. PubMed ID: 15080950
    [Abstract] [Full Text] [Related]

  • 16. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Brandes AA, Tosoni A, Basso U, Reni M, Valduga F, Monfardini S, Amistà P, Nicolardi L, Sotti G, Ermani M.
    J Clin Oncol; 2004 Dec 01; 22(23):4779-86. PubMed ID: 15570079
    [Abstract] [Full Text] [Related]

  • 17. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A, Bock HC, Brück W, Doerner L, Mehdorn HM, Roggendorf W, Westphal M, Felsberg J, Reifenberger G, Giese A.
    Br J Neurosurg; 2013 Dec 01; 27(6):772-8. PubMed ID: 23662801
    [Abstract] [Full Text] [Related]

  • 18. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system.
    Wolff SN, Phillips GL, Herzig GP.
    Cancer Treat Rep; 1987 Feb 01; 71(2):183-5. PubMed ID: 3026626
    [Abstract] [Full Text] [Related]

  • 19. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
    Kessinger A, Lemon HM, Foley JF.
    J Surg Oncol; 1978 Feb 01; 10(6):543-7. PubMed ID: 215846
    [Abstract] [Full Text] [Related]

  • 20. How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial.
    Brandes AA, Tosoni A, Amistà P, Nicolardi L, Grosso D, Berti F, Ermani M.
    Neurology; 2004 Oct 12; 63(7):1281-4. PubMed ID: 15477552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.